Diseases : DID32555 - Atopic neurodermatitis

ZScoreRScoreEntity TypeIDNameSynonyms
1.31707234506 30 - [0, 0, 1, 1] Diseases DID32555 Atopic neurodermatitis Atopic neurodermatitis; Atopic Dermatitis; Disseminated neurodermatitis; Besnier's prurigo; ECZEMA, ATOPIC; Atopic Eczema; AD - Atopic dermatitis; DERMATITIS ALLERGIC; Allergic eczema; Allergic dermatitis; BESNIER PRURIGO; Eczema, allergic; DERMATITIS ATOPIC; Canine atopy; DERMATITIS, ATOPIC; Atopic Neurodermatitis; ECZEMA ATOPIC; Allergic (intrinsic) eczema (disorder); Atopic dermatitis (disorder); Atopic dermatitis nos (disorder); Atopic neurodermatitis (disorder); Besnier's prurigo (disorder)
Back to View Results

RScore Document Snippets Details
25 - [0, 0, 1, 0] Exposure to phthalates and bisphenol A are associated with atopic dermatitis symptoms in children: a time-series analysis.
[MEDLINE : 28274229]
(2017) Exposure to phthalates and bisphenol A are associated with atopic dermatitis symptoms in children: a time-series analysis. Environmental health : a global access science source;Environ Health;2017 03;16(1):24

- Exposure to phthalates and bisphenol A are associated with atopic dermatitis symptoms in children: a time-series analysis.

Details
5 - [0, 0, 0, 1] Oral Administration of Bisphenol A Directly Exacerbates Allergic Airway Inflammation but Not Allergic Skin Inflammation in Mice.
[MEDLINE : 29846729]
(2018) Oral Administration of Bisphenol A Directly Exacerbates Allergic Airway Inflammation but Not Allergic Skin Inflammation in Mice. Toxicological sciences : an official journal of the Society of Toxicology;Toxicol. Sci.;2018 10;165(2):314-321

- Studies have indicated that BPA possibly exacerbates allergic diseases such as atopic dermatitis and asthma.

Details
Back to View Results
Legend


This project is supported by the Canadian Institutes of Health Research (award #111062), Alberta Innovates - Health Solutions, and by The Metabolomics Innovation Centre (TMIC), a nationally-funded research and core facility that supports a wide range of cutting-edge metabolomic studies. TMIC is funded by Genome Alberta, Genome British Columbia, and Genome Canada, a not-for-profit organization that is leading Canada's national genomics strategy with $900 million in funding from the federal government.